在非小细胞肺癌患者中,miR-10a-3p的预后值
Julija Simiene1,2, Linas Kunigenas1,2, Rimvile Prokarenkaite1,2
1Laboratory of Molecular Oncology, National Cancer Institute, Vilnius, LT-08406, Lithuania.
OncoTargets and therapy
|November 19, 2024
概括
这项研究确定了血miR-10a-3p作为非小细胞肺癌 (NSCLC) 进展的有希望的非侵入性生物标志物. 增加的miR-10a-3p水平与NSCLC患者的延长无进展生存时间相关.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 分子生物学分子生物学
背景情况:
- 非小细胞肺癌 (NSCLC) 患者的结局需要新的生物标志物来早期和不那么侵入性地检测.
- 微RNA (miRNA) 表达正在被探索为各种癌症的潜在诊断和预后工具.
研究的目的:
- 研究miRNA表达作为非小细胞肺癌 (NSCLC) 进展的生物标志物的潜力.
- 在3D细胞培养系统中培养的NSCLC细胞中选miRNA.
主要方法:
- 具有不同攻击性的NSCLC细胞系和非癌性支气管上皮细胞系在3D培养.
- 使用Illumina NGS.小RNA库被准备和测序使用Illumina NGS.
- 在89个配对的NSCLC组织和血样本中验证了差异表达的miRNAs.
主要成果:
- 下一代测序确定了NSCLC细胞系中8种差异表达的miRNA.
- 血miR-10a-3p显著增加,并与延长无进展生存期 (PFS) 相关 (p=0.009).
- 血miR-10a-3p是NSCLCPFS的一个显著的预后变量 (HR:0.5,p=0.029).
结论:
- 在3DNSCLC细胞培养中查miRNA表达,确定了潜在的生物标志物.
- 循环中的miR-10a-3p显示出作为一种新型,非侵入性生物标志物的潜力,用于NSCLC患者的短期预后.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


